What is the appropriate Lantus (glargine) dose and insulin regimen for a patient with a hemoglobin A1c (HbA1c) of 13.1%, transitioning off an insulin drip, with a body mass index (BMI) of 38 and impaired renal function (creatinine 0.77), who is new to insulin therapy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 22, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Insulin Regimen for DKA Transition in Insulin-Naïve Patient

Start Lantus at 20-25 units once daily (0.2 units/kg), use a carbohydrate ratio of 1:8 for meal coverage with rapid-acting insulin, and implement a correction scale starting at 2 units for glucose 150-200 mg/dL, increasing by 2 units for each 50 mg/dL increment. 1

Basal Insulin (Lantus) Dosing

For this 103 kg patient with severe hyperglycemia (A1C 13.1%) transitioning from insulin drip:

  • Calculate total 24-hour insulin from the drip, then give half as basal Lantus 1

    • If drip data unavailable, start at 0.2 units/kg = approximately 20-21 units once daily 1
    • The creatinine of 0.77 mg/dL indicates preserved renal function (normal for this patient), so no dose reduction needed 2
  • Given the markedly elevated A1C (13.1%) and obesity (BMI 38), consider starting at the higher end: 0.2-0.25 units/kg = 20-25 units 1

    • Start with 25 units Lantus once daily at bedtime for this severely hyperglycemic patient 1
  • Titrate by 2-4 units (or 10-15%) every 2-3 days based on fasting glucose, targeting fasting glucose 100-130 mg/dL 1, 3

Prandial (Mealtime) Insulin Coverage

This patient requires basal-bolus therapy given the severe hyperglycemia and DKA presentation:

  • Start rapid-acting insulin (lispro, aspart, or glulisine) at 4 units per meal or 10% of basal dose per meal = approximately 2-3 units 1

    • Given the A1C >10%, start with 4-5 units before each meal 1
  • Carbohydrate ratio: 1:8 (1 unit per 8 grams of carbohydrate) 4, 2

    • This aggressive ratio is appropriate for severe hyperglycemia and obesity 4
    • If postprandial glucose exceeds 250 mg/dL, tighten to 1:6 ratio 4, 2

Correction Scale (Sliding Scale)

Use the following correction insulin scale with rapid-acting insulin before meals and at bedtime:

Blood Glucose Additional Units
150-200 mg/dL 2 units
201-250 mg/dL 4 units
251-300 mg/dL 6 units
301-350 mg/dL 8 units
>350 mg/dL 10 units and notify provider

4, 2

  • This uses the "1800 rule" with correction factor of approximately 1 unit per 25 mg/dL above 150 mg/dL 4

Complete Initial Regimen Summary

For this 103 kg patient:

  • Lantus: 25 units once daily at bedtime 1
  • Rapid-acting insulin: 4-5 units before each meal 1
  • Carbohydrate coverage: Add 1 unit per 8 grams of carbohydrate 4, 2
  • Correction scale: As outlined above, administered with mealtime insulin 4, 2
  • Add metformin if not contraindicated (renal function is adequate) 1

Monitoring and Titration Protocol

  • Check blood glucose before each meal and at bedtime (minimum 4 times daily) 4, 2
  • Target glucose: 100-180 mg/dL 4
  • Increase Lantus by 2-4 units every 2-3 days if fasting glucose remains >130 mg/dL 1, 3
  • Adjust mealtime insulin by 1-2 units if postprandial glucose consistently >180 mg/dL 1

Critical Pitfalls to Avoid

  • Do not delay prandial insulin initiation - with A1C 13.1%, basal insulin alone will be insufficient 1
  • Avoid overbasalization - if bedtime-to-morning glucose differential exceeds 50 mg/dL, increase prandial rather than basal insulin 1
  • If hypoglycemia occurs (<70 mg/dL), reduce the corresponding insulin dose by 10-20% immediately 4, 2
  • Ensure patient education on hypoglycemia recognition and treatment before discharge 1
  • The progressive nature of diabetes means this regimen will require ongoing adjustment - schedule follow-up within 1-2 weeks 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

NPH Insulin and Carbohydrate Coverage for Steroid-Induced Hyperglycemia with Severe Renal Impairment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Hyperglycemia in Post-Kidney Transplant Patients on High-Dose Steroids

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.